Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

4,269 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Canada Legislates The Use Of Inventions During The Pandemic

    Under Bill C-13, emergency measures will now be available to Canadians and Canadian businesses.
    CanadaCoronavirus (COVID-19)
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    COVID-19: Canadian Government Can Now Use Patented Inventions To Respond To The Public Health Emergency

    In response to the COVID-19 pandemic, the government of Canada quickly gave itself the authority to use and even sell inventions that have been patented by others, to the extent necessary to respond to the public health emergency.
    CanadaCoronavirus (COVID-19)
    McCarthy Tétrault
    McCarthy Tétrault
Article

Patent Issues Under Canada's COVID-19 Emergency Response Act

The Federal Government's COVID-19 Emergency Response Act contains certain amendments to the Patent Act that permit the Federal Government authorize anyone to "make, construct, use and...
CanadaCoronavirus (COVID-19)
Field Law
Field Law
  • Article

    Ontario Not-for-Profit Corporations Act – Transition And Next Steps

    As we reported last week, the Ontario government announced that, after almost 11 years, the Ontario Not-for-Profit Corporations Act (ONCA) is finally being proclaimed into force effective October 19, 2021 (proclamation date).
    CanadaCorporate/Commercial Law
    Torkin Manes LLP
    Torkin Manes LLP
  • Article

    BLG Guide | Newly Updated And Expanded For 2022

    The fourth edition of Borden Ladner Gervais LLP's Life Sciences & Chemistry Patent Practice in Canada: A Practical Guide is now available...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Borden Ladner Gervais LLP
    Borden Ladner Gervais LLP
  • Article

    CDA Opens Consultation On Proposed List Of Drugs To Inform Development Of National Formulary

    On June 19, 2025, Canada's Drug Agency (CDA) opened a public consultation on a proposed process for preparing a list of essential prescription drugs and related products.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Competition Bureau Closes Two Investigations Into Pharmaceutical Patent Litigation Settlements

    On May 20, 2022, the Competition Bureau announced that it closed two investigations into pharmaceutical patent litigation settlement agreements as evidence gathered...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Video

    From Discovery To Market: The Role Of IP Strategy In Drug Development (Video)

    Brian Kingwell, a partner, patent agent, and trademark agent in the firm's Vancouver office, has more than two decades of experience in patent prosecution and strategic patent portfolio counselling.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Gowling WLG
    Gowling WLG
  • Article

    Intellectual Property Weekly Abstracts Bulletin - Week of June 13, 2011

    Appeal Allowing Amendments to Pleadings Dismissed. Drug: gemcitabine
    CanadaFood, Drugs, Healthcare, Life Sciences
    Borden Ladner Gervais LLP
    Borden Ladner Gervais LLP
  • Article

    Intellectual Property Weekly Abstracts Bulletin - Week of March 12, 2012

    The Federal Court of Appeal (FCA) upheld a decision of the Motions Judge, which upheld the decision of a Prothonotary, granting leave to the respondents to amend their pleadings.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Borden Ladner Gervais LLP
    Borden Ladner Gervais LLP
  • Article

    PMPRB Announces Next Steps In Guidelines Consultation Process

    As we reported, the Patented Medicine Prices Review Board (PMPRB) adopted its Amended Interim Guidance on September 27, 2023. The Interim Guidance provides information on how the PMPRB...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Cassels
    Cassels
  • Article

    PMPRB Interim Guidance Updated

    On August 18, 2022, PMPRB announced its Decision resulting from the consultation on the PMPRB Price Review Approach During the Interim Period following publication of Amendments to the Patented Medicines Regulation...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Fasken
    Fasken
  • Article

    Supreme Court Of Canada Dismisses First Section 8 Damages Appeal

    On April 20, 2015, the Supreme Court of Canada dismissed Sanofi-Aventis’ appeal concerning a claim by Apotex for section 8 damages under the Patented Medicines (Notice of Compliance) Regulations.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Gowling WLG
    Gowling WLG
  • Article

    A Sale In Canada Triggers Exhaustion Of Patent Rights In The US

    "Patent exhaustion" is something we've reviewed before. To recycle an old line, the term "patent exhaustion" does not refer to the feeling you get when a patent agent talks for 3 hours ...
    CanadaIntellectual Property
    Field Law
    Field Law
  • Article

    Abuse Of Process Clarified By Canadian Federal Court Of Appeal

    In a recent decision, Apotex Inc. v. Janssen-Ortho Inc, the Federal Court of Appeal has limited the scope of the abuse of process doctrine in applications under the Patented Medicines (Notice of Compliance) Regulations.
    CanadaIntellectual Property
    Torys
    Torys
  • Article

    Accelerated Patent Examination Now Available For Critical Mineral Technologies In Canada

    Canada's Intellectual Property Office has introduced a new expedited examination program for patent applications in critical technology areas, including a dedicated stream for innovations related to the processing, extraction, and refining of minerals on Canada's critical minerals list. The program offers accelerated patent examination on a first-come, first-served basis with specific eligibility requirements and annual application limits.
    CanadaIntellectual Property
    Gowling WLG
    Gowling WLG
  • Article

    Alberta Court Of Appeal Clarifies Limitation Period For Patent Infringement Claims

    The Alberta Court of Appeal has clarified the applicable limitation period for patent infringement claims commenced in Alberta courts in its recent decision...
    CanadaIntellectual Property
    Oyen Wiggs Green & Mutala
    Oyen Wiggs Green & Mutala
  • Article

    Amendments To Canadian Patent Examination Rules Come Into Force October 3, 2022

    Canada's federal government has registered certain amendments to Canada's Patent Rules pertaining to examination as final.
    CanadaIntellectual Property
    Torys
    Torys
  • Article

    Amendments To The Patent Rules Coming Into Force October 3, 2022

    Rules amending the Canadian Patent Rules were recently registered on June 2, 2022. The amendments will largely come into force on October 3, 2022.
    CanadaIntellectual Property
    Oyen Wiggs Green & Mutala
    Oyen Wiggs Green & Mutala
  • Article

    Apotex Not Permitted To Plead Promise-Based Invalidity Grounds In Ontario Section 8 Lansoprazole Action

    This motion arose in the context of a section 8 action in which Apotex claims damages for delay in the issuance of its notice of compliance for its generic lansoprazole product ...
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Showing 461–480 of 4269 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics